Propanc Biopharma Successfully Produces Synthetic Recombinant Trypsinogen Via POP1 Joint Research & Drug Discovery Program
Identifying a Backup Clinical Candidate for Projected $111B Global Metastatic Cancer Market MELBOURNE, Australia--(BUSINESS WIRE)--Propanc…